Prognostic value of serological and PET/CT response kinetics in patients with multiple myeloma treated with BCMA CAR-T.
Saved in:
| Title: | Prognostic value of serological and PET/CT response kinetics in patients with multiple myeloma treated with BCMA CAR-T. |
|---|---|
| Authors: | Gustine JN; Department of Oncology, Massachusetts General Hospital, Harvard Medical School, Boston, MA, USA., Scaringi JA; Department of Radiology, Massachusetts General Hospital, Harvard Medical School, Boston, MA, USA., Bauer F; Institute for Diagnostic and Interventional Radiology, Faculty of Medicine and University Hospital Cologne, University of Cologne, Cologne, Germany., Cirstea DD; Department of Oncology, Massachusetts General Hospital, Harvard Medical School, Boston, MA, USA., Branagan AR; Department of Oncology, Massachusetts General Hospital, Harvard Medical School, Boston, MA, USA., Puliafito BR; Department of Oncology, Massachusetts General Hospital, Harvard Medical School, Boston, MA, USA., Maus MV; Department of Oncology, Massachusetts General Hospital, Harvard Medical School, Boston, MA, USA., Frigault MJ; Department of Oncology, Massachusetts General Hospital, Harvard Medical School, Boston, MA, USA., Yee AJ; Department of Oncology, Massachusetts General Hospital, Harvard Medical School, Boston, MA, USA., Mahmood U; Department of Radiology, Massachusetts General Hospital, Harvard Medical School, Boston, MA, USA., Raje NS; Department of Oncology, Massachusetts General Hospital, Harvard Medical School, Boston, MA, USA. nraje@mgh.harvard.edu. |
| Source: | Leukemia [Leukemia] 2026 Feb; Vol. 40 (2), pp. 440-443. Date of Electronic Publication: 2025 Dec 19. |
| Publication Type: | Journal Article |
| Journal Info: | Publisher: Nature Publishing Group, Specialist Journals Country of Publication: England NLM ID: 8704895 Publication Model: Print-Electronic Cited Medium: Internet ISSN: 1476-5551 (Electronic) Linking ISSN: 08876924 NLM ISO Abbreviation: Leukemia Subsets: MEDLINE; In Process |
| Database: | MEDLINE Ultimate |
Be the first to leave a comment!
